Clonally related follicular lymphomas and langerhans cell neoplasms: Expanding the spectrum of transdifferentiation

American Journal of Surgical Pathology

Volumn 37, Issue 7, 2013, Pages 978-986

  West, Dava S ^a   Dogan, Ahmet ^a   Quint, Patrick S ^a   Tricker Klar, Melissa L ^a   Porcher, Julie C ^a   Ketterling, Rhett P ^a   Law, Mark E ^a   McPhail, Ellen D ^a   Viswanatha, David S ^a   Kurtin, Paul J ^a   Dao, Linda N ^a   Ritzer, Ryan D ^a   Nowakowski, Grzegorz S ^b   Feldman, Andrew L ^a,b  

^a Department of Laboratory Medicine and Pathology ^*  (United States)

^b MAYO CLINIC   (United States)

Author keywords

Follicular lymphoma; Langerhans cell histiocytosis; Langerhans cell sarcoma; Lineage plasticity; Transdifferentiation; Transformation

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; IMMUNOGLOBULIN HEAVY CHAIN;

AGED; ARTICLE; CASE REPORT; CELL CLONE; CELL TRANSDIFFERENTIATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOPHENOTYPING; LANGERHANS CELL; LANGERHANS CELL SARCOMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SECOND CANCER;

AGED; CELL TRANSDIFFERENTIATION; CLONE CELLS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LANGERHANS CELL SARCOMA; LANGERHANS CELLS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 84880278385     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318283099f     Document Type: Article

References (42)

1. Montecino-Rodriguez E, Leathers H, Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol. 2001;2:83-88.
2. Hou YH, Srour EF, Ramsey H, et al. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood. 2005;105:3488-3492.
3. Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117:663-676.
4. Feldman AL, Minniti C, Santi M, et al. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5:248-250.
5. McClure R, Khoury J, Feldman A, et al. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases. Leuk Res. 2010;34:e71-e73.
6. Dictor M, Warenholt J, Gyorgy C, et al. Clonal evolution to histiocytic sarcoma with the BCR/ABL rearrangement 14 years after acute lymphoblastic leukemia. Leuk Lymphoma. 2009;50: 1892-1895.
7. Castro EC, Blazquez C, Boyd J, et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010;13:225-237.
8. Kumar R, Khan SP, Joshi DD, et al. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer. 2011;56:307-310.
9. Rodig SJ, Payne EG, Degar BA, et al. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol. 2008;83:116-121.
10. Feldman AL, Berthold F, Arceci RJ, et al. Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 2005;6:435-437.
11. Feldman AL, Arber DA, Pittaluga S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433-5439.
12. Shao H, Xi L, Raffeld M, et al. Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24:1421-1432.
13. Fraser CR, Wang W, Gomez M, et al. Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. Am J Clin Pathol. 2009;132:928-939.
14. Wang E, Papalas J, Hutchinson CB, et al. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual. Am J Surg Pathol. 2011;35:457-463.
15. Zeng W, Meck J, Cheson BD, et al. Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor. J Cutan Pathol. 2011;38:999-1003.
16. Bassarova A, Troen G, Fossa A, et al. Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation. J Hematop. 2009;2:135-141.
17. Neumann MP, Frizzera G. The coexistence of Langerhans' cell granulomatosis and malignant lymphoma may take different forms: report of seven cases with a review of the literature. Hum Pathol. 1986;17:1060-1065.
18. Egeler RM, Neglia JP, Aricó M, et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am. 1998;12:369-378.
19. Adu-Poku K, Thomas DW, Khan MK, et al. Langerhans cell histiocytosis in sequential discordant lymphoma. J Clin Pathol. 2005;58:104-106.
20. Almanaseer IY, Kosova L, Pellettiere EV. Composite lymphoma with immunoblastic features and Langerhans' cell granulomatosis (histiocytosis X). Am J Clin Pathol. 1986;85:111-114.
21. Magni M, Di Nicola M, Carlo-Stella C, et al. Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leuk Res. 2002;26:1131-1133.
22. Kurtin PJ, Hobday KS, Ziesmer S, et al. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am J Clin Pathol. 1999;112:319-329.
23. Morice WG, Kurtin PJ, Leibson PJ, et al. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol. 2003;120: 1026-1036.
24. Einerson RR, Kurtin PJ, Dayharsh GA, et al. FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol. 2005;124:421-429.
25. Wada DA, Law ME, Hsi ED, et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol. 2011;24:596-605.
26. van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:201-206.
27. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
28. Freedman A. Follicular lymphoma: 2011 update on diagnosis and management. Am J Hematol. 2011;86:768-775.
29. Harris NL, Swerdlow SH, Jaffe ES, et al. Follicular lymphoma. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2008:220-226.
30. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med. 1984;311:1471-1475.
31. Lossos IS, Gascoyne RD. Transformation of follicular lymphoma. Best Pract Res. 2011;24:147-163.
32. Jaffe R, Weiss LM, Facchetti F. Tumours derived from Langerhans cells. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2008:358-360.
33. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615-619.
34. Ginhoux F, Merad M. Ontogeny and homeostasis of Langerhans cells. Immunol Cell Biol. 2010;88:387-392.
35. Anjuére F, del Hoyo GM, Martin P, et al. Langerhans cells develop from a lymphoid-committed precursor. Blood. 2000;96: 1633-1637.
36. Feldman AL, Berthold F, Arceci R, et al. Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 2005;6:435-437.
37. Chen W, Wang J, Wang E, et al. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis. Am J Surg Pathol. 2010;34:1049-1057.
38. Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature. 2007;449:473-477.
39. Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:1919-1923.
40. Sahm F, Capper D, Preusser M, et al. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012;120:e28-e34.
41. Rodriguez-Galindo C, Kelly P, Jeng M, et al. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am J Hematol. 2002;69:179-184.
42. Donadieu J, Chalard F, Jeziorski E. Medical management of langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother. 2012;13:1309-1322.